SARS-CoV-2 positivity – Communicable Diseases Research

The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil

Research article

Published on 2022-12-012022-10-05
Journal: Public Health in Practice
[Category] 진단,

Clinical trial and detection of SARS-CoV-2 by a commercial breath analysis test based on Terahertz technology

Article

Published on 2022-09-202022-11-15
Journal: PLoS ONE
[Category] SARS, 치료기술,

COVID-19 Disease in Presenting to the Pediatric Emergency Department: A Multicenter Study of 8886 Cases

Observational Study

Published on 2022-09-012022-10-04
Journal: The American journal of emergency medicine
[Category] COVID19(2023년), SARS, 임상,

[키워드] Admission age all age groups antibody Asymptomatic Characteristics children Chronic illness chronic illnesses Clinical course Clinical outcome Clinical severity Contact cough COVID-19 COVID-19 disease decrease diagnosed diagnosis of SARS-CoV-2 Emergency epidemiological evaluate Fever groups Hospital admission Hospital admissions hospitals household contact Infection Inflammatory intensive care Laboratory male median age Mild MIS-C MOST multicenter multicenter study Observational cohort study pandemic Patient patients PCR PCR positivity PCR-positive PCR-positive individuals PCR-positive patient pediatric performed polymerase chain Prognosis radiologic retrospective SARS-CoV-2 SARS-CoV-2 PCR SARS-CoV-2 positivity SARS-CoV-2. Shock specimen Symptom Symptoms syndrome the median the patient therapeutic strategy treatment strategy were recorded while
[DOI] 10.1016/j.ajem.2022.06.015 PMC 바로가기 [Article Type] Observational Study

Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry

Article

Published on 2022-08-152022-11-16
Journal: Respiratory Research
[Category] SARS, 치료기술,

[키워드] adjusted Affect Analysis antiplatelet association Atherosclerosis baseline baseline characteristics cardiovascular disease cardiovascular risk Characteristics chronic chronic obstructive COPD COVID COVID-19 COVID-19 pandemic Diagnosis discharge dissimilarity Impact In-hospital In-hospital death independent International Mortality multicenter Myocardial infarction Obstructive occurred outcome outcomes pandemic pathophysiological mechanism Patient patients Percutaneous coronary intervention prognostic proportion pulmonary disease SARS-CoV-2 positivity significant difference significantly significantly higher STEMI. subject therapy treated two groups
[DOI] 10.1186/s12931-022-02128-0 PMC 바로가기

Evaluation of a potential prognostic parameter for the inflammatory status in COVID-19 patients: The inflammatory protein ratio

COVID-19 환자의 염증 상태에 대한 잠재적인 예후 매개변수 평가: 염증 단백질 비율

Article

Published on 2022-08-012022-09-11
Journal: Electrophoresis
[Category] COVID19(2023년), SARS, 치료기술,

[키워드] albumin all the patients ANOVA C-reactive protein calculated Chain Reaction controls coronavirus disease Coronavirus disease 2019 correlation COVID-19 COVID-19 patient CRP D-dimer dimer fibrinogen Globulin hospitalized patient Human plasma immuno-turbidimetric assay immunoassay Inflammatory inflammatory protein inflammatory state inflammatory status Interpretation involved Kruskal-Wallis mathematical Nasopharyngeal swab nasopharyngeal swabs parameter parameters Pearson performed polymerase chain polymerase chain reaction prognostic proportionality Protein qualitative test quantified real time real time Polymerase Chain Reaction RNA RT-PCR SARS-CoV-2 SARS-CoV-2 positivity separated Serum protein serum protein electrophoresis. serum proteins Significant significantly Spearman the patient unique variance
[DOI] 10.1002/elps.202100396 PMC 바로가기 [Article Type] Article

Rapid syndromic testing for respiratory viral infections in children attending the emergency department during COVID-19 pandemic in Lille, France, 2021-2022

2021-2022년 프랑스 릴에서 COVID-19 전염병 동안 응급실에 다니는 어린이의 호흡기 바이러스 감염에 대한 신속한 증후군 검사

Article

Published on 2022-08-012022-09-11
Journal: Journal of Clinical Virology
[Category] COVID19(2023년), SARS, 변종, 치료기술,

[키워드] Alpha variant both groups children circulation collected COVID-19 pandemic Delta disease Emergency emergency department enterovirus France Genome sequencing hospital Human Human rhinovirus in both groups Infection intensive care intensive care unit majority median median age molecular MOST multiplex Mutation nasopharyngeal swabs non-specific omicron Omicron variant Omicron variants Other Other respiratory viruses outpatients Panel Patient PCR-based assay pediatric positive Prevalence prevalent ranged Rapid respiratory respiratory infection respiratory infections respiratory syncytial virus respiratory viral infection respiratory virus respiratory viruses rhinovirus Sample SARS-CoV-2 SARS-CoV-2 infected patient SARS-CoV-2 infected patients SARS-COV-2 infection SARS-CoV-2 positivity SARS-CoV-2 variant screened severe disease significant increase Symptoms Syndromic testing. treated variant variants viral infections viral respiratory infections was performed
[DOI] 10.1016/j.jcv.2022.105221 PMC 바로가기 [Article Type] Article

Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic

코로나19 팬데믹 기간 동안 이탈리아 선천성 면역질환 환자의 단클론항체 및 항바이러스제 실생활 데이터

Article

Published on 2022-07-282022-09-11
Journal: Frontiers in Immunology
[Category] COVID19(2023년), SARS, 진단, 치료제,

[키워드] Alpha Analysis Antiviral antiviral agent Antiviral agents antiviral drug antiviral drugs Asymptomatic Care circulating Cohort contributed Course COVID-19 COVID-19 pandemic COVID-19 severity disease disease severity duration of viral shedding Effect Efficacy error evaluated Hospital admission Hospitalization hospitalization-risk hospitalizations hospitalized patients ICU admission Immunity immunized Inborn Inborn errors inborn errors of immunity Infection Italian longitudinal lower risk mAbs mitigate monoclonal monoclonal antibodies monoclonal antibody Mortality mRNA vaccine mRNA vaccines offered Patient patients treated performed positive Prevent prophylactic measure prophylactic measures Re-infection Re-infections reduce reduced Reinfection reinfection. reported respond risk Safe SARS-CoV-2 SARS-CoV-2 infected patients SARS-CoV-2 positivity SARS-CoV-2 strains SARS-CoV-2 virus severe COVID-19 severe disease Spectrum Spread Strains therapeutic therapy treated vaccination Vaccinations Viral viral shedding viral strain viral strains widespread
[DOI] 10.3389/fimmu.2022.947174 PMC 바로가기 [Article Type] Article

Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial

Randomized Controlled Trial

Published on 2022-07-262022-10-05
Journal: Nutrients
[Category] COVID19(2023년), SARS, 임상,

Global influenza surveillance systems to detect the spread of influenza-negative influenza-like illness during the COVID-19 pandemic: Time series outlier analyses from 2015-2020

COVID-19 전염병 동안 인플루엔자 음성 인플루엔자 유사 질병의 확산을 감지하기 위한 글로벌 인플루엔자 감시 시스템: 2015-2020년의 시계열 이상치 분석

Article

Published on 2022-07-192022-09-11
Journal: PLoS Medicine
[Category] COVID19(2023년), SARS, 치료기술,

[키워드] analysis Analysis analyzed ARIMA automated average baseline changes in Completeness country COVID-19 COVID-19 case COVID-19 pandemic data-driven detect disease emerging disease evaluate exceeded first positive Health Organization highest identify ILI Influenza interpolation limitation linear linear interpolation Missing data moving average National observation occurred Outbreaks outlier outliers pathogen performed Poland positive primary analysis reported response SARS-CoV-2 SARS-CoV-2 positivity sensitivity analysis Spain Spread spread of COVID-19 Standard deviation Surveillance surveillance data surveillance network System time training data used data World Health Organization
[DOI] 10.1371/journal.pmed.1004035 PMC 바로가기 [Article Type] Article

COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study

COVID-19 백신 약화 및 부스터의 효과 및 부작용: ZOE COVID 연구의 전향적 커뮤니티 연구

Article

Published on 2022-07-012022-09-11
Journal: The Lancet. Infectious Diseases
[Category] COVID19(2023년), SARS, 변종,

[키워드] 95% CI Adverse reaction Adverse reactions Alpha Analysis B.1.1.7 BNT162b2 booster booster dose booster doses ChAdOx1 ChAdOx1 nCoV-19 chronic chronic disease Community community setting Comorbidities completion confounder confounders Control country COVID COVID-19 COVID-19 vaccine dose effective Effectiveness fatigue foundation group Heterologous heterologous schedule heterologous schedules homologous schedule individual Infection investigated Local local symptom Medical Research Council mRNA mRNA-1273 mRNA1273 nCoV new SARS-CoV-2 Odds ratio Older participant Participants Pfizer-BioNTech Poisson regression model positive reactogenicity receiving regimens remained reported SARS-CoV-2 SARS-CoV-2 positivity SARS-CoV-2 test second dose self-reported systemic Side-effect Side-effects Symptom systemic systemic side-effect Systemic side-effects systemic symptom tenderness test result tested those with comorbidities vaccinated individual vaccinated individuals vaccination Vaccine vaccine dose variant variants waned Wellcome Trust
[DOI] 10.1016/S1473-3099(22)00146-3 PMC 바로가기 [Article Type] Article